Clearmind Medicine Inc
CNSX:CMND
Balance Sheet
Balance Sheet Decomposition
Clearmind Medicine Inc
Clearmind Medicine Inc
Balance Sheet
Clearmind Medicine Inc
| Oct-2017 | Oct-2018 | Oct-2019 | Oct-2020 | Oct-2021 | Oct-2022 | Oct-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
3
|
0
|
5
|
|
| Cash |
0
|
0
|
0
|
0
|
3
|
0
|
5
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
4
|
0
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+91%
|
0
-28%
|
0
+111%
|
4
+918%
|
1
-78%
|
6
+620%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-88%
|
0
+483%
|
0
-78%
|
0
+2 604%
|
2
+628%
|
5
+157%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
1
|
6
|
7
|
17
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
2
|
8
|
16
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
+278%
|
0
-44%
|
0
+174%
|
4
+873%
|
1
N/A
|
1
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+91%
|
0
-28%
|
0
+111%
|
4
+918%
|
1
-78%
|
6
+620%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|